Blood high mobility group box 1 levels are not a suitable biomarker for disease activity or severity in nonsegmental vitiligo.

Park, S; Lee, E J; Kim, J Y; Bae, Y J; Oh, S H

Park, S; Lee, E J; Kim, J Y; Bae, Y J; Oh, S H.

Afiliación

Park S; Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Lee EJ; Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Kim JY; Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Bae YJ; Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Oh SH; Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Clin Exp Dermatol ; 46(8): 1597-1599, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34080225

Asunto(s)

Biomarcadores/sangre; Proteína HMGB1/sangre; Índice de Severidad de la Enfermedad; Vitíligo/sangre; Adulto; Femenino; Humanos; Masculino; Persona de Mediana Edad; Vitíligo/clasificación

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vitíligo / Índice de Severidad de la Enfermedad / Biomarcadores / Proteína HMGB1 Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Dermatol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google